UNSPSC 51285501: Clazuril

This classification denotes an antiparasitic agent with the molecular formula C17H10Cl2N4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier O8W0R05772, chemically known as benzeneacetonitrile, 2-chloro-alpha-(4-chlorophenyl)-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3h)-yl)- but generally known as clazuril, which bears US NIH Compound Identifier 58901. European Medicines Agency schedules Clazuril in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06645MIG.

UNSPSC 51285501 Clazuril is a Commodity code nominally covering a specific antiprotozoal veterinary pharmaceutical, but recent state and local activity under this code shows little relevant purchasing. The two records in the recent-opportunities block—an Illinois Department of Public Health pharmaceutical piggyback contract for Doxycycline Hyclate and Ciprofloxacin Hydrochloride, and a Seminole County, Florida procurement for Naloxone and drug deactivation systems—are unrelated to clazuril and appear to reflect miscoding in the state and local procurement databases rather than genuine demand for the named product. State and local purchasing offices do occasionally tag pharmaceutical and medical-supply solicitations with incorrect or proximate UNSPSC codes, particularly when sourcing through cooperative purchasing vehicles or when the procurement system does not offer a precise commodity match.

No open solicitations or active RFPs, RFQs, ITBs, or IFBs for clazuril itself appear in the recent records. Firms pursuing work under this code should verify whether actual clazuril demand exists within their target jurisdictions—particularly state agriculture departments, state veterinary regulatory bodies, or local animal-control agencies that might stock the product—rather than relying on the database activity shown here, which does not reflect genuine market signals for the commodity.